Spotlight on Metastatic Breast Cancer
In 2024 alone, approximately 297,790 women and 2,800 men will be diagnosed with breast cancer, and it’s estimated that up to 30 percent of patients will develop metastatic disease.
That’s why Spotlight on Metastatic Breast Cancer takes an in-depth look at the driving forces and innovations behind the latest diagnostic and treatment advances, featuring expert insights from leading clinicians and researchers dedicated to the fight against this disease.
1-15 of 24
Closing the Evidence Gap in Metastasis-Directed Therapy for mBC
Project Oncology®Closing the Evidence Gap in Metastasis-Directed Therapy for mBC
Lajos Pusztai, MD, DPhil
Is There a Role for Primary Tumor Surgery in Metastatic Breast Cancer?
Project Oncology®Is There a Role for Primary Tumor Surgery in Metastatic Breast Cancer?
Lajos Pusztai, MD, DPhil
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Ryan Quigley
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Predicting Breast Cancer Metastasis with Proteomics
Project Oncology®Predicting Breast Cancer Metastasis with Proteomics
- advertisement
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Project Oncology®Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Treatment Selection Strategies for Metastatic Breast Cancer Patients
Project Oncology®Treatment Selection Strategies for Metastatic Breast Cancer Patients
Sarah Sammons, MD
Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Project Oncology®Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Sarah Sammons, MD
Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Project Oncology®Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Sarah Sammons, MD
Breast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
Project Oncology®Breast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
Basak Dogan, MD
- advertisement
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
Project Oncology®When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
Pavani Chalasani, MD, MPH
Jose Pablo Leone, MD
Approaches to Utilizing Bone-targeting Therapies in mBC
Project Oncology®Approaches to Utilizing Bone-targeting Therapies in mBC
Pavani Chalasani, MD, MPH
Gabriel N. Hortobagyi, MD
The Role of PARP Inhibitors in Metastatic Breast Cancer
Project Oncology®The Role of PARP Inhibitors in Metastatic Breast Cancer